Protalix BioTherapeutics
PLX
#8897
Rank
โ‚ฌ0.12 B
Marketcap
1,51ย โ‚ฌ
Share price
1.45%
Change (1 day)
-9.49%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): -0,03824ย โ‚ฌ

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is -0,03436ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 0,03436ย โ‚ฌ a decrease over its 2023 EPS that were of 0,10ย โ‚ฌ.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,03824ย โ‚ฌ-211.29%
20240,03436ย โ‚ฌ-66.67%
20230,10ย โ‚ฌ-138.71%
2022-0,27ย โ‚ฌ-50%
2021-0,53ย โ‚ฌ181.82%
2020-0,19ย โ‚ฌ-82.11%
2019-1,06ย โ‚ฌ-31.67%
2018-1,55ย โ‚ฌ-72.31%
2017-5,58ย โ‚ฌ124.14%
2016-2,49ย โ‚ฌ-147.54%
20155,24ย โ‚ฌ-290.63%
2014-2,75ย โ‚ฌ6.67%
2013-2,58ย โ‚ฌ130.77%
2012-1,12ย โ‚ฌ-69.77%
2011-3,69ย โ‚ฌ19.44%
2010-3,09ย โ‚ฌ-12.2%
2009-3,52ย โ‚ฌ36.67%
2008-2,58ย โ‚ฌ-37.5%
2007-4,12ย โ‚ฌ50%
2006-2,75ย โ‚ฌ3.23%
2005-2,66ย โ‚ฌ138.46%
2004-1,12ย โ‚ฌ-74%
2003-4,30ย โ‚ฌ-0%
2002-4,30ย โ‚ฌ-50%
2001-8,59ย โ‚ฌ233.33%
2000-2,58ย โ‚ฌ-83.9%
1999-16,01ย โ‚ฌ-24%
1998-21,07ย โ‚ฌ-600%
19974,21ย โ‚ฌ-16.67%
19965,06ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-0,09450ย โ‚ฌ 175.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
3,70ย โ‚ฌ-10,875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,48ย โ‚ฌ-4,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-1,675.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel